Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.
2.

First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.

Kiel K, Cremer FW, Ehrbrecht E, Wallmeier M, Hegenbart U, Goldschmidt H, Moos M.

Bone Marrow Transplant. 1998 Jun;21(11):1109-15.

3.

Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapy.

Kallmeyer C, Wallmeier M, Kiel K, Moos M, Hegenbart U, Haas R, Goldschmidt H.

Am J Hematol. 1998 Apr;57(4):287-92.

4.

Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatment.

Goldschmidt H, Salwender HJ, Hahn U, Hegenbart U, Egerer G, Wallmeier M, Jansen B, Haas R.

Zentralbl Bakteriol. 1998 Jan;287(1-2):125-34.

PMID:
9532271
5.

High-dose chemotherapy in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Moos M, Haas R.

Leukemia. 1997 Dec;11 Suppl 5:S27-31. Review.

PMID:
9436935
7.

Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R.

Recent Results Cancer Res. 1998;144:27-35.

PMID:
9304704
8.

A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma.

Cremer FW, Kiel K, Wallmeier M, Goldschmidt H, Moos M.

Ann Oncol. 1997 Jul;8(7):633-6.

PMID:
9296214
9.

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R.

Ann Oncol. 1997 Mar;8(3):243-6.

PMID:
9137792
10.

[Malignant lymphoma. Pathology, diagnosis, therapy].

Goldschmidt H, Wallmeier M, Hegenbart U, Haas R.

Radiologe. 1997 Jan;37(1):1-9. Review. German.

PMID:
9157471

Supplemental Content

Loading ...
Support Center